参考文献/References:
［1］World Health Organization. Human papillomavirus infection and cervicalcancer ［J］. Geneva:WHO Available at: on January 13, 2011(2003): 1-74.
［2］Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v10, cancer incidence and mortality worldwide: IARC Cancer Base No. 11 ［EB/OL］. http://globocan. iarc.fr. Retrieved September 3, 2015.
［3］赫捷，陈万青.中国肿瘤登记年报（2012）［M］.军事医学科学出版社，2012.
［4］Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities［M］. Rockville (MD): National Cancer Institute, Center to Reduce Cancer Health Disparities,2005.
［5］DENNY L, KUHN L, POLLACK A, et al. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance ［J］. Cancer, 2002, 94 (6): 1699-1707.
［6］GAFFIKIN L, LAUTERBACH M, BLUMENTHAL P D. Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date ［J］. Obstetrical & Gynecological Survey, 2003, 58 (8): 543-550.
［7］Sankaranarayanan R, Basu P, Wesley RS, et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa ［J］. Int J Cancer ，2004，110（6）:907-913.
［8］MISHRA G A, DHIVAR H D, GUPTA S D, et al. A population-based screening program for early detection of common cancers among women in India - methodology and interim results ［J］. Indian Journal of Cancer, 2016, 52(1): 139-145.
［9］Nayar R, Wilbur DC. The Pap Test and Bethesda 2014［J］. Cancer Cytopathol， 2015，123（5）:271-281.
［10］GUSTAFSSON L, PONTN J, ZACK M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening ［J］. Cancer Causes & Control : CCC, 1997, 8 (5): 755-763.
［11］ARBYN M, BERGERON C, KLINKHAMER P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis ［J］. Obstetrics and Gynecology, 2008, 111 (1) : 167-177.
［12］SIEBERS A G, KLINKHAMER P J, GREFTE J M, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial ［J］. JAMA : the Journal of the American Medical Association, 2009, 302 (16): 1757-1764.
［13］Castle PE, Stoler MH, Wright TC Jr,et al. 2011. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study ［J］. Lancet Oncol,2011，12 （9）:880-890.
［14］ACOP Bulletinsgynecology.ACOG Practice Bulletin no. 109: Cervical cytology screening ［J］. Obstet Gynecol,2009，114(6):1409-1420.
［15］SCHIFFMAN M, RODRIGUEZ A C, CHEN Zigui, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia ［J］. Cancer Research, 2010, 70 (8): 3159-3169.
［16］MASSAD L S, EINSTEIN M H, HUH W K, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors ［J］. Journal of Lower Genital Tract Disease, 2013, 17 (5 Suppl 1): S1-S27.
［17］PAN Qin-jing, HU Shang-ying, GUO Hui-qin, et al. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China ［J］. Gynecologic Oncology, 2014, 133 (2): 172-179.
［18］WHITLOCK E P, VESCO K K, EDER M, et al. Burda BU liquid-based cytology and human papillomavirus testing to screen for cervical cancer:a systematic review for the U ［J］. S.Preventive Services Task Force.Ann Intern Med, 2011, 155 (10): W214-W215.
相似文献/References:
[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[5]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[6]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[7]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(5):0.
[8]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[9]闵爱萍.刺猬蛋白在宫颈癌组织中的表达及其临床意义[J].中国计划生育和妇产科,2014,(07):0.
MIN Ai-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(5):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.